A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.
Rodríguez-Cid JR, Chards SC, González-Espinoza IR, García-Montes V, Garibay-Díaz JC, Hernández-Flores O, Riera-Sala R, Gozalishvili-Boncheva A, Alatorre-Alexander JA, Martínez-Barrera LM, Sánchez-Ríos CP, Martinez-Camacho A, Martínez-Herrera JF, Guzmán-Casta J, Flores-Mariñelarena RR, Diaz-Rico J, Santillán-Doherty P.
Rodríguez-Cid JR, et al.
Lung Cancer Manag. 2021 Mar 11;10(3):LMT47. doi: 10.2217/lmt-2020-0027. eCollection 2021 Sep.
Lung Cancer Manag. 2021.
PMID: 34408789
Free PMC article.